Allergy Diagnostic Assay Kits

Allergy Diagnostic Assay Kits Market Outlook

The global allergy diagnostic assay kits market is projected to reach approximately USD 3.1 billion by 2035, growing at a compound annual growth rate (CAGR) of around 8.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of allergies, heightened awareness regarding allergic conditions, and advancements in diagnostic technologies. Moreover, the rising demand for rapid and accurate diagnostic tools, coupled with an increase in the healthcare expenditure, is expected to fuel the market growth. The surge in the aging population and the growing incidence of food allergies and respiratory conditions further contribute to this upward trajectory, positioning the market for sustained development in the coming years.

Growth Factor of the Market

The growth of the allergy diagnostic assay kits market can be attributed to several key factors. Firstly, the increasing prevalence of allergic diseases, including food allergies and asthma, has created a substantial demand for effective diagnostic tools. As more individuals are diagnosed with allergies, healthcare systems are compelled to adopt advanced testing methodologies to ensure precise diagnoses. Secondly, growing awareness among the general population regarding allergy symptoms and the potential severity of allergic reactions drives demand for comprehensive testing. Thirdly, advancements in technology, such as the introduction of molecular diagnostic techniques and automation in diagnostic laboratories, have led to quicker and more reliable testing results. Additionally, the involvement of government and non-profit organizations in promoting allergy awareness and research initiatives is helping to propel market growth. Furthermore, the rising trend of personalized medicine is creating opportunities for tailored allergy diagnostics, thereby expanding the market landscape.

Key Highlights of the Market

• Projected market size of USD 3.1 billion by 2035.
• Compound annual growth rate (CAGR) of approximately 8.5% from 2025 to 2035.
• Increasing prevalence of allergies enhances demand for diagnostic kits.
• Technological advancements in diagnostic methodologies are driving market growth.
• Rising public awareness regarding allergic conditions and their management.

By Product Type

In Vivo Testing Kits:

In vivo testing kits play a crucial role in the allergy diagnostic assay kits market, particularly for their ability to provide real-time data on patient responses to allergens. These kits are designed for use directly on the patient, allowing for immediate assessment of allergic reactions through methods such as skin prick tests. The increasing demand for accurate and rapid diagnoses of allergies is bolstering the growth of this segment. Healthcare providers are adopting in vivo testing kits due to their ease of use and the ability to deliver quick results, which is essential for timely patient management. The market for in vivo testing kits is expected to witness significant growth as awareness about allergies continues to rise among healthcare professionals and patients alike.

In Vitro Testing Kits:

In vitro testing kits are an integral component of the allergy diagnostic assay kits market, offering advanced laboratory-based testing solutions. These kits analyze biological samples outside of a living organism, providing valuable insights into the patient's allergic profile. The increasing adoption of in vitro testing methods is driven by their high specificity and sensitivity, making them a preferred choice among clinicians. Moreover, advances in technology such as enzyme-linked immunosorbent assays (ELISA) and other immunoassays have enhanced the accuracy and reliability of these tests. The growing trend of laboratory automation and the need for comprehensive diagnostics are anticipated to drive the growth of the in vitro testing kits segment in the coming years.

Patch Testing Kits:

Patch testing kits are specifically designed for the diagnosis of contact dermatitis and other skin allergies. They are predominantly used in dermatological practices, allowing healthcare professionals to identify allergens that may cause skin reactions. The rise in the incidence of skin allergies due to environmental factors and skincare products is fueling the demand for patch testing kits. Furthermore, the growing emphasis on personalized medicine is driving the development of more sophisticated patch testing methodologies. The segment for patch testing kits is expected to experience robust growth, as clinicians increasingly recognize the importance of accurate skin allergy diagnostics for effective treatment plans.

Skin Prick Testing Kits:

Skin prick testing kits are widely used for diagnosing immediate hypersensitivity reactions, making them a staple in allergy clinics. This method involves introducing small amounts of allergens into the skin and monitoring for reactions. The simplicity and effectiveness of skin prick tests contribute to their popularity among healthcare providers. The growing prevalence of respiratory allergies, particularly allergic rhinitis and asthma, is expected to drive the demand for skin prick testing kits. As awareness of these conditions increases, more patients are seeking allergy evaluations, further propelling the growth of this segment in the market.

Molecular Diagnostic Testing Kits:

Molecular diagnostic testing kits represent a cutting-edge segment within the allergy diagnostic assay kits market, utilizing advanced techniques to detect specific allergens at the molecular level. These kits enable precise diagnosis and profiling of allergic conditions, offering significant advantages over traditional testing methods. The rapid advancements in molecular biology and biotechnology are driving the development of innovative diagnostic solutions, enhancing the overall effectiveness of allergy testing. As more healthcare providers embrace molecular diagnostics for their high sensitivity and specificity, this segment is poised for considerable growth in the upcoming years.

By Application

Food Allergies:

The application of allergy diagnostic assay kits for food allergies is a rapidly expanding segment of the market, fueled by the rising incidence of food-related allergic reactions. With growing awareness regarding food allergies, particularly among children, there is a significant demand for effective testing solutions to identify specific allergens. Diagnostic kits that target food allergies facilitate the swift identification of problematic foods, allowing individuals to manage their diets proactively. The market for food allergy diagnostics is projected to grow as awareness and education on food allergies continue to increase, prompting healthcare systems to integrate these tests into standard care protocols.

Respiratory Allergies:

Respiratory allergies, including allergic rhinitis, asthma, and other respiratory conditions, are a leading application area for allergy diagnostic assay kits. The increasing prevalence of airborne allergens such as pollen, dust mites, and pet dander is driving the need for effective diagnostic tools. The ability of diagnostic kits to rapidly identify specific allergens enables healthcare providers to prescribe targeted therapies and improve patient outcomes. The respiratory allergy diagnostics market is expected to witness significant growth due to the rising awareness of allergic conditions and the growing willingness of individuals to seek diagnostic testing.

Drug Allergies:

Drug allergies represent a critical area of concern within the allergy diagnostic assay kits market. As the complexity of pharmacological treatments increases, so does the risk of allergic reactions to medications. Diagnostic kits specifically designed to identify drug allergies play a vital role in ensuring patient safety during treatment. With the growing emphasis on personalized medicine and the need for accurate allergy profiling before initiating pharmacotherapy, the demand for drug allergy diagnostic kits is anticipated to rise. This segment's growth is further supported by ongoing research and initiatives aimed at understanding and managing drug allergies more effectively.

Skin Allergies:

Skin allergies encompass a wide range of conditions, including atopic dermatitis, allergic contact dermatitis, and urticaria, necessitating accurate diagnostic tools to guide treatment decisions. Allergy diagnostic assay kits designed for skin allergies enable healthcare providers to identify specific triggers and tailor treatment plans accordingly. The growing prevalence of skin allergies, exacerbated by environmental factors and lifestyle changes, is driving the need for these diagnostic solutions. As public awareness regarding skin allergies increases, the demand for effective allergy testing is expected to grow, further enhancing this segment of the market.

Others:

Other applications of allergy diagnostic assay kits include diagnostic solutions for less common allergies and multi-allergen testing. This segment caters to a diverse range of allergic conditions that may not fall under traditional categories. The growing trend of personalized medicine and the need for comprehensive allergy profiles are encouraging the development of diagnostic kits catering to various allergies. The demand for such versatile solutions is likely to rise as healthcare providers seek to address a broader spectrum of allergic reactions, thus expanding the overall market for allergy diagnostic assay kits.

By Distribution Channel

Hospitals:

The hospital segment represents a significant distribution channel for allergy diagnostic assay kits, as hospitals are primary healthcare facilities that often provide comprehensive diagnostic services. The integration of specialized allergy testing within hospital settings enhances patient care and management of allergic conditions. Hospitals are increasingly adopting advanced diagnostic technologies, including allergy testing kits, to streamline their operations and improve patient outcomes. The demand within hospitals for these diagnostic tools is expected to grow as healthcare systems prioritize effective allergy management and invest in innovative testing methodologies.

Clinics:

Allergy clinics are dedicated facilities that focus specifically on the diagnosis and treatment of allergic conditions, making them key distribution channels for allergy diagnostic assay kits. These clinics often utilize a range of testing methods to ensure accurate diagnosis and effective treatment. The increasing number of specialized allergy clinics and the growing prevalence of allergies are driving the demand for diagnostic kits within this segment. As more patients seek tailored allergy evaluations, clinics are likely to enhance their offerings with the latest diagnostic solutions, further contributing to market growth.

Diagnostic Laboratories:

Diagnostic laboratories are essential players in the allergy diagnostic assay kits market, providing critical testing services to healthcare providers and patients. These laboratories are equipped with advanced technologies that enable them to perform a myriad of allergy tests efficiently. The demand for allergy testing in diagnostic laboratories is on the rise due to the increasing awareness of allergic conditions and the need for timely and accurate diagnoses. Partnerships between diagnostic laboratories and healthcare providers are expected to strengthen, driving further growth in this segment as laboratories enhance their testing capabilities and expand their service offerings.

Retail Pharmacies:

Retail pharmacies are emerging as a growing distribution channel for allergy diagnostic assay kits, particularly with the rising trend of self-testing and home diagnostics. Over-the-counter allergy testing kits empower consumers to take proactive measures in identifying potential allergens without the need for immediate medical consultation. The increasing prevalence of allergies and the growing availability of consumer-friendly diagnostic solutions are contributing to the growth of this segment. Retail pharmacies are likely to expand their product offerings to meet the rising demand for accessible allergy testing options, ultimately enhancing their market presence.

Online Sales:

The online sales channel for allergy diagnostic assay kits has gained momentum in recent years, further accelerated by the COVID-19 pandemic. E-commerce platforms provide consumers with convenient access to a wide range of diagnostic kits, allowing them to compare products and make informed decisions from the comfort of their homes. The growing trend of telehealth services and the increasing adoption of digital health solutions are driving online sales of allergy diagnostic kits. As more consumers embrace online shopping and remote healthcare options, the online sales channel is expected to witness significant growth, revolutionizing the way allergy diagnostics are accessed and utilized.

By Technology

ELISA:

Enzyme-linked immunosorbent assay (ELISA) technology is a widely used method in the allergy diagnostic assay kits market, known for its sensitivity and specificity in detecting allergens. ELISA tests allow for the quantitative measurement of specific antibodies related to allergy symptoms, providing valuable insights for healthcare providers. The increasing adoption of ELISA technology in clinical settings is driven by its ability to deliver accurate results in a relatively short turnaround time. As healthcare providers seek reliable diagnostic tools for allergy testing, the demand for ELISA-based allergy diagnostic kits is expected to grow.

PCR:

Polymerase chain reaction (PCR) technology is becoming increasingly relevant in the allergy diagnostic assay kits market due to its ability to identify specific allergenic genetic material. PCR-based diagnostic kits enable healthcare providers to detect allergens with high sensitivity and specificity, facilitating the management of allergic conditions. The growing trend of genetic testing and the need for precise allergy diagnostics are driving the demand for PCR technology in this market segment. As advancements in PCR technology continue to enhance its effectiveness, its adoption for allergy diagnostics is anticipated to rise significantly over the coming years.

Immunoassay:

Immunoassay technology encompasses a broad range of techniques used in allergy diagnostics, including both traditional and modern methods. These assays utilize antigen-antibody interactions to detect specific allergens and are favored for their accuracy and reliability. The growing emphasis on personalized medicine and the need for comprehensive allergy testing are propelling the adoption of immunoassays in clinical settings. As healthcare providers seek innovative diagnostic solutions to address the complexities of allergic conditions, the immunoassay segment is poised for considerable growth in the market.

Microarray:

Microarray technology offers a cutting-edge approach to allergy diagnostics by enabling simultaneous testing of multiple allergens in a single assay. This high-throughput method allows healthcare providers to generate comprehensive allergen profiles for individual patients, facilitating targeted treatment strategies. The increasing demand for multiplex testing solutions is driving the adoption of microarray technology within the allergy diagnostic assay kits market. As advancements in microarray technology enhance its accuracy and efficiency, this segment is expected to witness significant growth as healthcare providers seek to optimize allergy diagnostics.

Others:

The 'Others' category encompasses various emerging technologies and methodologies in the allergy diagnostic assay kits market, including lateral flow assays and point-of-care testing solutions. These innovative technologies aim to provide rapid and user-friendly diagnostic options for patients and healthcare providers alike. As public demand for accessible and timely allergy testing increases, this segment is expected to gain traction. The growing interest in novel diagnostic approaches is anticipated to contribute to the expansion of this segment, as companies invest in research and development to create cutting-edge allergy diagnostic solutions.

By Region

The North American region is expected to dominate the allergy diagnostic assay kits market, driven by the high prevalence of allergic conditions and advanced healthcare infrastructure. The increasing awareness among the population regarding allergies, combined with the presence of key market players and innovation in diagnostic technologies, is propelling market growth in this region. It is projected to account for approximately 35% of the global market share by 2035, with a CAGR of around 9% during the forecast period. The healthcare policies in the region are also favorable, promoting research and development in allergy diagnostics.

In Europe, the allergy diagnostic assay kits market is anticipated to experience robust growth, attributed to the rising awareness of allergic conditions and the increasing number of allergy clinics. Europe is expected to capture around 30% of the global market, with significant investments in healthcare services and growing consumer preference for advanced diagnostic solutions. As more individuals seek allergy testing, the demand for diagnostic kits is expected to rise in the region, further contributing to its market growth. Additionally, favorable regulations and initiatives aimed at improving healthcare access will support the expansion of the allergy diagnostics market across Europe.

Opportunities

The allergy diagnostic assay kits market presents numerous opportunities, particularly in the realm of technological advancements. As the field of diagnostics continues to evolve, the integration of artificial intelligence (AI) and machine learning into allergy testing processes holds significant promise. These technologies can enhance the accuracy of diagnoses, streamline workflows, and minimize human error, while also providing healthcare providers with predictive analytics and better patient management tools. Companies that focus on developing and implementing AI-enhanced diagnostic solutions may find themselves at the forefront of the market, meeting the growing demand for efficient and reliable allergy diagnostics.

Furthermore, the growing trend of personalized medicine offers substantial opportunities for the allergy diagnostic assay kits market. Consumers are increasingly seeking tailored healthcare solutions that cater to their individual needs. By offering customized allergy testing kits and services, companies can effectively address the unique requirements of patients. Developing kits that allow for comprehensive profiling of allergies, including food, skin, and respiratory allergies, can cater to the rising demand for precision medicine. As healthcare providers prioritize personalized approaches to patient care, this segment of the market is likely to see significant growth.

Threats

Despite the promising growth potential of the allergy diagnostic assay kits market, several threats could hinder its expansion. One of the primary challenges is the presence of stringent regulatory requirements governing the approval and commercialization of diagnostic kits. Compliance with these regulations can be time-consuming and costly, posing barriers for new entrants and smaller companies attempting to innovate within the market. Additionally, the rapidly changing landscape of healthcare regulations could impact operational efficiencies and market access for companies offering allergy diagnostic solutions. The need for continuous monitoring and adaptation to regulatory changes could strain resources and limit growth opportunities.

Another threat to the allergy diagnostic assay kits market is the existence of competitive alternatives and home-testing kits. As awareness of allergies grows, so does the availability of at-home testing solutions, which may pose a challenge to traditional diagnostic methods. Consumers may opt for these convenient options, impacting the demand for professional diagnostic services. Furthermore, the accuracy and reliability of at-home tests can vary significantly, raising concerns about potential misdiagnoses and undermining confidence in allergy diagnostics. Companies that fail to adapt to this changing landscape may face declining market shares and reduced profitability.

Competitor Outlook

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• BD (Becton, Dickinson and Company)
• Danaher Corporation
• Alere Inc.
• Quest Diagnostics
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche AG
• Ortho Clinical Diagnostics
• Eurofins Scientific
• LabCorp
• Agilent Technologies, Inc.

The competitive landscape of the allergy diagnostic assay kits market is characterized by the presence of several key players who are actively involved in innovation, product development, and strategic partnerships. With the increasing demand for effective allergy diagnostics, companies are investing heavily in research and development to enhance their product offerings and maintain their competitive edge. Major players are focusing on expanding their geographic reach and diversifying their product portfolios to cater to the evolving needs of healthcare providers and patients. The collaboration between established companies and startups is also becoming more prevalent, fostering innovation in allergy diagnostic technologies.

Thermo Fisher Scientific Inc. is a leading player in the allergy diagnostic assay kits market, known for its comprehensive portfolio of diagnostic solutions. The company continually invests in research and development to enhance its product offerings and has established a strong global presence. Merck KGaA is another major player that focuses on developing advanced diagnostic tools for allergy testing, leveraging its expertise in the life sciences sector. With a commitment to innovation and sustainability, Merck is well-positioned to capitalize on the growing demand for allergy diagnostics.

Roche Diagnostics is renowned for its cutting-edge diagnostic technologies, including allergy diagnostic assay kits. The company emphasizes the importance of personalized medicine and is actively pursuing new partnerships to expand its product range. Abbott Laboratories also plays a significant role in the allergy diagnostic market, with a diverse portfolio that includes rapid testing solutions. By focusing on technological advancements and improving patient access to allergy testing, Abbott aims to strengthen its market position. Overall, the allergy diagnostic assay kits market is poised for substantial growth, driven by ongoing innovations and increasing awareness of allergic conditions.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 LabCorp
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Alere Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Merck KGaA
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Quest Diagnostics
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Roche Diagnostics
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Abbott Laboratories
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Danaher Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Eurofins Scientific
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Hoffmann-La Roche AG
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Siemens Healthineers
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Ortho Clinical Diagnostics
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 BD (Becton, Dickinson and Company)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Allergy Diagnostic Assay Kits Market, By Application
    • 6.1.1 Food Allergies
    • 6.1.2 Respiratory Allergies
    • 6.1.3 Drug Allergies
    • 6.1.4 Skin Allergies
    • 6.1.5 Others
  • 6.2 Allergy Diagnostic Assay Kits Market, By Product Type
    • 6.2.1 In Vivo Testing Kits
    • 6.2.2 In Vitro Testing Kits
    • 6.2.3 Patch Testing Kits
    • 6.2.4 Skin Prick Testing Kits
    • 6.2.5 Molecular Diagnostic Testing Kits
  • 6.3 Allergy Diagnostic Assay Kits Market, By Distribution Channel
    • 6.3.1 Hospitals
    • 6.3.2 Clinics
    • 6.3.3 Diagnostic Laboratories
    • 6.3.4 Retail Pharmacies
    • 6.3.5 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Allergy Diagnostic Assay Kits Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Allergy Diagnostic Assay Kits market is categorized based on

By Product Type

• In Vivo Testing Kits
• In Vitro Testing Kits
• Patch Testing Kits
• Skin Prick Testing Kits
• Molecular Diagnostic Testing Kits

By Application

• Food Allergies
• Respiratory Allergies
• Drug Allergies
• Skin Allergies
• Others

By Distribution Channel

• Hospitals
• Clinics
• Diagnostic Laboratories
• Retail Pharmacies
• Online Sales

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• BD (Becton, Dickinson and Company)
• Danaher Corporation
• Alere Inc.
• Quest Diagnostics
• Bio-Rad Laboratories, Inc.
• Hoffmann-La Roche AG
• Ortho Clinical Diagnostics
• Eurofins Scientific
• LabCorp
• Agilent Technologies, Inc.